Using NK4 in this model, we provided the first evidence that HGF- antagonist can arrest tumor invasion in vivo [16]: recombinant NK4 inhibited the growth and muscular invasion in mice bearing GB-d1 carcinoma. The gene discussed is IL32; the disease is carcinoma.